Diuresis by intravenous administration of xanthurenic acid in rats, and inhibition by probenecid

被引:0
|
作者
Uwai, Yuichi [1 ]
Nakashima, Yuta [1 ]
Honjo, Emi [1 ]
Kawasaki, Tatsuya [1 ]
Nabekura, Tomohiro [1 ]
机构
[1] Aichi Gakuin Univ, Sch Pharm, Dept Pharmaceut, Chikusa Ku, Nagoya, Aichi 4648650, Japan
来源
BIOMEDICAL RESEARCH-TOKYO | 2014年 / 35卷 / 03期
基金
日本学术振兴会;
关键词
TRANSPORT; OAT1;
D O I
10.2220/biomedres.35.223
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The conjugates with sulfate and glucoside of xanthurenic acid, a tryptophan metabolite, were reported to show natriuresis. Sulfotransferase for xanthurenic acid works in the renal proximal tubule to produce the sulfate of xanthurenic acid as well as the liver, and we recently found that xanthurenic acid is a substrate of renal organic anion transporter OAT1. The purpose of this study was to examine relationship between the transport by OAT1 and diuresis related with xanthurenic acid. Drug transport experiment using Xenopus laevis oocytes represented that probenecid inhibited xanthurenic acid uptake by rat OAT1 (rOAT1). Although no diuresis was recognized by the intravenous injection of xanthurenic acid as a bolus in rats, the addition of its infusion exhibited natriuresis. Simultaneous administration of probenecid significantly decreased the urine volume and excreted amounts of sodium into urine. These findings showed the diuresis by the xanthurenic acid administration, and it was probenecid-sensitive. The rOAT1-mediated transport of xanthurenic acid might, at least in part, contribute to its diuretic effect.
引用
收藏
页码:223 / 226
页数:4
相关论文
共 50 条
  • [21] RENAL CLEARANCE OF PANTOTHENIC ACID IN MAN - INHIBITION BY PROBENECID (BENEMID)
    BOGER, WP
    BAYNE, GM
    GYLFE, J
    WRIGHT, LD
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1953, 82 (04): : 604 - 608
  • [22] 5-HYDROXYINDOLE ACETIC-ACID AND HOMOVANILLIC ACID IN CEREBROSPINAL-FLUID AFTER INTRATHECAL AND INTRAVENOUS ADMINISTRATION OF PROBENECID TO NORMAL AND HYDROCEPHALIC DOGS
    ANDERSSON, H
    ESSEN, CV
    ROOS, BE
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1973, 32 (1-2): : 139 - 147
  • [23] EFFECT OF ACETOACETATE ON URINARY EXCRETION OF XANTHURENIC ACID AND OTHER TRYPTOPHAN METABOLITES IN RATS
    NATH, MC
    SHASTRI, NV
    BRITISH JOURNAL OF NUTRITION, 1969, 23 (01) : 153 - &
  • [24] Xanthurenic acid and its role in the tryptophane metabolism of pyridoxine- deficient rats
    Lepkovsky, S
    Roboz, E
    Haagen-Smit, AJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1943, 149 (01) : 195 - 201
  • [25] STUDIES ON EFFERENT MECHANISM OF SODIUM DIURESIS WHICH FOLLOWS ADMINISTRATION OF INTRAVENOUS SALINE IN DOG
    DEWARDENER, H
    CLAPHAM, WF
    MILLS, IH
    HAYTER, CJ
    CLINICAL SCIENCE, 1961, 21 (02) : 249 - &
  • [26] Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice
    Hori, Y
    Ohyanagi, H
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1997, 27 (02): : 140 - 144
  • [27] The identification and pharmacokinetic studies of metabolites of salvianolic acid B after intravenous administration in rats
    Qi Qu
    Hao Kun
    Li Fei-Yan
    Cao Li-Juan
    Wang Guang-Ji
    Hao Hai-Ping
    CHINESE JOURNAL OF NATURAL MEDICINES, 2013, 11 (05) : 560 - 565
  • [28] Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice
    Yuichi Hori
    Harumasa Ohyanagi
    Surgery Today, 1997, 27 : 140 - 144
  • [29] Gamma-hydroxybutyric acid decreases intravenous cocaine self-administration in rats
    Martellotta, MC
    Balducci, C
    Fattore, L
    Cossu, G
    Gessa, GL
    Pulvirenti, L
    Fratta, W
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 59 (03) : 697 - 702
  • [30] Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats
    Jeong, Dong Won
    Kim, Young Hoon
    Kim, Hui Hyun
    Ji, Hye Young
    Yoo, Sun Dong
    Choi, Won Rack
    Lee, Soo Min
    Han, Chang-Kyun
    Lee, Hye Suk
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (02) : 51 - 57